This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: The Rockefeller University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Nigel John Liverton: Innovator in Cellular Proliferation and Hearing Loss Treatment
Introduction: Nigel John Liverton is an inventor based in San Antonio, TX (US). He is currently associated with The Rockefeller University. Although he has not been granted any patents, his work focuses on significant advancements in cellular proliferation and methods for treating hearing loss.
Latest Patent Applications: Nigel John Liverton has filed several patent applications, including "Pyrrolopyridine-3- and 4-Carboxamide Compositions and Methods for Cellular Proliferation." This application discloses N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides, N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-4-carboxamides, and N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[3,2-b]pyridine-1-carboxamides. These compounds are designed to activate Yap and inhibit Lats kinases, making them useful for treating hearing loss. Another application is titled "Pyrrolo[2,3-b]pyridine-3-Carboxamide Compositions and Methods for Ameliorating Hearing Loss," which includes N-(3-substituted thiazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides and N-(3-substituted oxazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides.
Conclusion: Nigel John Liverton is a dedicated inventor whose work aims to advance the fields of cellular proliferation and hearing loss treatment. His innovative patent applications reflect his commitment to addressing significant health challenges.